KCNQ5

protein-coding

potassium voltage-gated channel subfamily Q member 5, the group of Potassium voltage-gated channels

Gene summary

This gene is a member of the KCNQ potassium channel gene family that is differentially expressed in subregions of the brain and in skeletal muscle. The protein encoded by this gene yields currents that activate slowly with depolarization and can form heteromeric channels with the protein encoded by the KCNQ3 gene. Currents expressed from this protein have voltage dependences and inhibitor sensitivities in common with M-currents. They are also inhibited by M1 muscarinic receptor activation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]

MANE transcript

NM_019842.4

Inheritance

AD

ClinVar variants

P:40U:377B:364

Top phenotype

Intellectual developmental disorder, autosomal dominant 46

gnomAD constraint

pLI —, LoF o/e 0.17

Max pathogenic AF

—

Genomic locus

chr6:72,621,792-73,198,853

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~577.1 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

intellectual developmental disorder, autosomal dominant 46STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0030911

Submitter: PanelApp Australia

intellectual developmental disorder, autosomal dominant 46LIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0030911

Submitter: G2P

autosomal dominant non-syndromic intellectual disabilitySUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0015802

Submitter: Orphanet

intellectual developmental disorder, autosomal dominant 46STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0030911

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

Intellectual developmental disorder, autosomal dominant 46AD

Manifestation: Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 28669405Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to KCNQ5 variants in ClinVar

12 Conditions Cataloged
not providedTotal: 799
Inborn genetic diseasesTotal: 104
not specifiedTotal: 80
Intellectual disability, autosomal dominant 46Total: 79
KCNQ5-related disorderTotal: 42
Intellectual disabilityTotal: 4
Prostate cancerTotal: 1
Autosomal dominant non-syndromic intellectual disabilityTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_019842.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
4
clinvar
229
clinvar
8
clinvar
241
missense
8
clinvar
14
clinvar
351
clinvar
71
clinvar
52
clinvar
496
nonsense
3
clinvar
4
clinvar
10
clinvar
17
start loss
1
clinvar
1
clinvar
2
frameshift
6
clinvar
4
clinvar
9
clinvar
4
clinvar
23
splice donor/acceptor (+/-2bp)
2
clinvar
2
Total182237730460781

Highest pathogenic variant AF is 0.000003717403

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 23 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_019842.4RefSeqNP_062816.214MANE Select
ENST00000370398.6EnsemblENSP00000359425.114MANE Select
NM_001160130.2RefSeqNP_001153602.113Standard
NM_001160132.2RefSeqNP_001153604.114Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Cholinergic synapse - Homo sapiens (human)
  • Celecoxib Pathway, Pharmacodynamics
  • ion channels and their functional role in vascular endothelium
  • Neuronal System
  • Voltage gated Potassium channels

Biological Process

  • regulation of ion transmembrane transport
  • potassium ion transmembrane transport

Molecular Function

  • voltage-gated potassium channel activity
  • delayed rectifier potassium channel activity
  • protein binding
  • calmodulin binding

Cellular Component

  • plasma membrane
  • integral component of plasma membrane
  • voltage-gated potassium channel complex
  • integral component of membrane
  • clathrin coat

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000342056
Coding exons
15
Length
577055
Individuals with no LoFs
125708
Homozygous LoFs
0
Heterozygous LoFs
40
Defined
125748
p
0.000159
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense3.322894970.5810.00002766134
Missense (PolyPhen)45173.740.2592005
Synonymous-1.802191881.170.00001091926
Loss of Function5.29847.20.1690.00000294513

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000120.00012rare
Latino/Admixed American0.0000290.000029rare
Ashkenazi Jewish0.000100.000099rare
East Asian0.0000540.000054rare
Finnish0.00120.0012notable
European (Non-Finnish)0.0000790.000079rare
South Asian00.0absent
Other0.000160.00016rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Associates with KCNQ3 to form a potassium channel which contributes to M-type current, a slowly activating and deactivating potassium conductance which plays a critical role in determining the subthreshold electrical excitability of neurons. Therefore, it is important in the regulation of neuronal excitability. May contribute, with other potassium channels, to the molecular diversity of a heterogeneous population of M- channels, varying in kinetic and pharmacological properties, which underlie this physiologically important current. Insensitive to tetraethylammonium, but inhibited by barium, linopirdine and XE991. Activated by niflumic acid and the anticonvulsant retigabine. As the native M-channel, the potassium channel composed of KCNQ3 and KCNQ5 is also suppressed by activation of the muscarinic acetylcholine receptor CHRM1. {ECO:0000269|PubMed:10787416, ECO:0000269|PubMed:11159685, ECO:0000269|PubMed:28669405}.;
Disease
DISEASE: Mental retardation, autosomal dominant 46 (MRD46) [MIM:617601]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD46 patients manifest developmental delay and mild to moderate intellectual disability. {ECO:0000269|PubMed:28669405}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.118

Intolerance Scores

LoFtool
0.0121
RVIS EVS
-0.73
RVIS percentile EVS
14.08

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
K
Indispensability pred.
E
Indispensability score
0.760

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.